Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
57.70M | 53.82M | 55.07M | 36.18M | 14.59M | 9.54M | Gross Profit |
7.37M | 12.23M | 23.08M | 14.60M | 6.72M | 5.01M | EBIT |
-9.23M | -7.23M | 10.30M | 4.43M | 1.17M | 854.34K | EBITDA |
-7.24M | -5.21M | 11.73M | 5.54M | 1.33M | 988.92K | Net Income Common Stockholders |
-9.73M | -6.34M | 8.52M | 4.06M | 911.00K | 432.67K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.36M | 6.36M | 3.22M | 4.07M | 4.28M | 3.62M | Total Assets |
47.42M | 47.42M | 48.36M | 28.20M | 11.62M | 6.57M | Total Debt |
6.70M | 6.70M | 7.93M | 191.00K | 5.18M | 2.16M | Net Debt |
333.00K | 333.00K | 4.70M | -3.88M | 899.00K | -1.45M | Total Liabilities |
28.45M | 28.45M | 23.35M | 11.76M | 9.35M | 5.26M | Stockholders Equity |
18.96M | 18.96M | 25.02M | 16.44M | 2.28M | 1.31M |
Cash Flow | Free Cash Flow | ||||
892.00K | 5.00M | -4.20M | 392.00K | -1.76M | 1.39M | Operating Cash Flow |
1.88M | 6.39M | -3.04M | 3.66M | 4.74K | 1.43M | Investing Cash Flow |
-1.39M | -1.77M | -2.77M | -8.38M | -1.76M | -40.91K | Financing Cash Flow |
-1.79M | -2.02M | 4.97M | 4.50M | 2.43M | 1.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | £608.12M | 14.38 | 8.21% | 3.51% | 15.51% | 4.30% | |
65 Neutral | $12.05B | 15.92 | 6.71% | 4.32% | 8.04% | 3.76% | |
63 Neutral | £7.51B | 32.20 | 7.64% | 4.88% | 5.38% | 86.34% | |
56 Neutral | £6.68B | 59.05 | 6.17% | 5.24% | 8.61% | ― | |
51 Neutral | £1.98B | ― | -0.82% | 8.66% | 20.25% | -128.71% | |
45 Neutral | £11.30M | ― | -33.42% | ― | 1.44% | -251.55% |